Danaher (CHIX:DAPD) Research & Development: €1,380 Mil (TTM As of Mar. 2026)


CHIX:DAPD Danaher Corp CHIX:DAPD
72 GF Score
Price €203.00
GF Value €254.72
! 4 Warning Signs
View Full Analysis

What is Danaher Research & Development?

Danaher CHIX:DAPD 72 Research & Development is €1,380 Mil as of Mar. 2026. GuruFocus rates CHIX:DAPD with a GF Score™ of 72/100 and a GF Value™ of €254.72. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Danaher's Research & Development for the three months ended in Mar. 2026 was €335 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €1,380 Mil.

Danaher  (CHIX:DAPd) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Danaher Research & Development Related Terms

Danaher Research & Development Historical Data

* Premium members only.

The historical data trend for Danaher's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danaher Research & Development Chart

Danaher Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,325.73 1,442.43 1,378.25 1,512.72 1,364.69

Danaher Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 350.58 349.40 322.06 374.05 334.76
CHIX:DAPD
72GF Score
Danaher Corp CHIX:DAPD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danaher Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,380 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €1,380 Mil mean?
Danaher (CHIX:DAPD) has a Research & Development of €1,380 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Danaher and its competitors.
Is Danaher's Research & Development too high?
Danaher's current Research & Development is €1,380 Mil. Overall, Danaher has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Danaher's Research & Development compare to TMO and IDXX?
Danaher's Research & Development of €1,380 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Danaher and its competitors. Danaher's current Research & Development is €1,380 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danaher stock overvalued right now?
Danaher (CHIX:DAPD) has a current Research & Development of €1,380 Mil. The stock's GF Value™ is €254.72, compared to a current price of €203.00 — trading 20.3% below its estimated fair value. The current Research & Development is €1,380 Mil. Danaher's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Danaher (CHIX:DAPD), the current Research & Development is €1,380 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Danaher (CHIX:DAPD) Overvalued in 2026?

Based on GuruFocus' analysis, Danaher stock appears to be undervalued. The current stock price of €203.00 is trading 20.3% below its estimated GF Value™ of €254.72.

Key valuation signals for CHIX:DAPD:

  • Research & Development: €1,380 Mil
  • GF Value™: €254.72 vs. price of €203.00 (20.3% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the CHIX:DAPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Danaher Business Description

Address 2200 Pennsylvania Avenue, NW, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
72GF Score

Get the complete analysis for CHIX:DAPD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€203.00
Price
€254.72
GF Value